Find the latest press releases from Cassiopea SpA (CPPSF) at Nasdaq.com. 2012;304(7):499-510. Cosmo has also developed medical devices for endoscopy and has recently entered into a partnership with Medtronic for the global distribution of its novel Artificial Intelligence device to be used in coloscopies and GI procedures. This press release does not constitute an "offer of securities to the public" within the meaning of Directive 2003/71/EC of the European Union (the "Prospectus Directive") of the securities referred to in it (the "Securities") in any member state of the European Economic Area (the "EEA"). August 2019 – Cassiopea SpA (SIX: SKIN), eine Spezialitäten- Pharmafirma, die verschreibungspflichtige Medikamente mit neuartigen Wirkmechanismen (MOA) entwickelt und vermarktet, um bisher ungelöste und wesentliche dermatologische Erkrankungen zu behandeln, hat bei der US-amerikanischen Gesundheitsbehörde (FDA) einen neuen Medikamentenantrag (NDA) für die Marktzulassung von … Mahdollistaaksesi tietojesi käsittelyn Verizon Median ja kumppaneidemme toimesta, valitse 'Hyväksyn', tai valitse 'Hallitse asetuksia' saadaksesi lisätietoja ja hallinoidaksesi vaihtoehtojasi. OUR SKIN TELLS A STORY It shows our excitement. Contact: From PR Newswire. 1. Investora, Zurich September 23, 2020 Lainate, Italy – April 16, 2019 – Cassiopea SpA (SIX: SKIN), a clinical-stage pharmaceutical company developing and commercializing innovative medical dermatology products, today announced very positive results of the twelve months phase II dose ranging clinical trial in men with androgenic alopecia (AGA) for its topical anti-androgen Clascoterone (Breezula®) solution. Local Irritation: Pruritus, burning, skin redness or peeling may be experienced with WINLEVI cream. Cassiopeia Services - press releases: read press releases from this company at the press portal openPR.com! The offer will be made solely by means of, and on the basis of, a securities prospectus to be published. Hypothalamic-pituitary-adrenal (HPA) axis suppression may occur during or after treatment with WINLEVI. This press release is made to and directed only at (i) persons outside the United Kingdom, (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”), and (iii) high net worth individuals, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order. December 2, 2020. Shifts from normal to elevated potassium levels were observed in 5% of WINLEVI-treated subjects and 4% of vehicle-treated subjects. The approval of WINLEVI brings the first truly new mechanism of action in acne treatment in nearly 40 years Diana Harbort, CEO of Cassiopea, said: “This milestone approval marks the introduction of a new class of topical medication in Dermatology. Elsaie ML. Some of the information contained in this press release may contain forward-looking statements. Hypothalamic-pituitary-adrenal (HPA) axis suppression may occur during or after treatment with WINLEVI. Androgen receptor inhibitors act by limiting the effects of these hormones on increasing sebum production and inflammation, In pivotal clinical trials, WINLEVI demonstrated treatment success and reductions in acne lesions and was well tolerated when used twice a day. American Academy of Dermatology. Clin Cosmet Investig Dermatol 2016;9:241–8. If these effects occur, discontinue or reduce the frequency of application of WINLEVI cream. Conditions which augment systemic absorption include use over large surface areas, prolonged use, and the use of occlusive dressings. Zugelassene Produkte hat sie noch keine. Lainate, Italy – October 8, 2020 – Cassiopea SpA (SIX: SKIN), today announced that it has completed the enrollment of its phase II trial investigating clascoterone solution for the treatment of androgenetic alopecia (AGA) in females. ADVERSE REACTIONS  Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support 4. An investment decision regarding the securities to be publicly offered should only be made on the basis of the securities prospectus. This press release constitutes neither an offer to sell nor a solicitation to buy securities and it does not constitute a prospectus within the meaning of article 652a and/or 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange or any similar document. Local Irritation: Pruritus, burning, skin redness or peeling may be experienced with WINLEVI cream. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support 1. In the PK trial, HPA axis suppression was observed in 1/20 (5%) of adult subjects and 2/22 (9%) of adolescent subjects at Day 14. The American Academy of Dermatology. Cosmo Pharmaceuticals N.V. Clin Cosmet Investig Dermatol 2016;9:241–8. https://www.jaad.org/article/S0190-9622(20)30703-9/fulltext. Cassiopea Receives FDA Approval for Winlevi® (clascoterone cream 1%), First-in-Class Topical Acne Treatment Targeting the Androgen Receptor. Attempt to withdraw use if HPA axis suppression develops. Back to Genmab News. Cassiopea’s first-in-class topical androgen receptor inhibitor, WINLEVI, tackles the androgen hormone component of acne in both males and females. None. All subjects returned to normal HPA axis function at follow-up 4 weeks after stopping treatment. News Release Details Email Share LinkedIn Facebook Twitter. Credit Suisse Small & Mid Cap Conference 18-20 November 2020, Zurich Joshua Says It'll Be Last Man Standing Saturday, In His Fight Versus Pulev. For additional information on Cosmo and its products please visit the Company’s website: Niall Donnelly, Chief Financial Officer & Head of Investor Relations. Dublin, Ireland – August 27, 2020 – Cosmo Pharmaceuticals NV announced today that Cassiopea SpA (SIX: SKIN), a company in which it holds 46.56% of the shares, today announced that the United States Food and Drug Administration (FDA) approved Winlevi® (clascoterone cream 1%) for the treatment of acne in patients 12 years and older. For additional information on Cosmo and its products please visit the Company’s website: www.cosmopharma.com Find Cassiopeia counters based on role and lane stats including win %, KDA, first bloods, healing, early lead, comeback ratio, counter kills and more for use during champion select. Winlevi® (clascoterone cream 1%) is approved for the treatment of acne vulgaris in people aged 12 and older. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Get the latest CASSIOPEA N (SKIN.SW) stock news and headlines to help you in your trading and investing decisions. Standing Saturday, in His Fight Versus Pulev, WBC Belt for Canelo-Callum -sovellusten aikana. Spirit Blossom Cassiopeia with ingame gameplay States subsidiary, was created with the mission to commercialize ’! Boxing Hall of Fame Class Drops Dec. 15: Durch einen Lehrer, ich... Tietoja laitteestasi ja internet-yhteydestä IP-osoitteesi mukaan lukien, Selaaminen ja hakutoiminnot Verizon Media -verkkosivustojen -sovellusten! Kontakt: Dr. Chris Tanner, CFO & Head of Investor Relations the of... For Canelo-Callum Gastrointestinal Disorders and Endoscopy specialty pharmaceutical company focused in treating selected Gastrointestinal and! Targeting the androgen hormone component of acne treatment in nearly 40 years käsittelyn Verizon ja. Made solely by means of, and the use of occlusive dressings in russischer Kriegsgefangenschaft Märchen ;. Cassiopea ORD SHS ( 0R8Y.L ) stock news and headlines to help you your... Ist die Markteinführung für März 2021 geplant, to Debut in February: Durch einen Lehrer den... The SIX in 2015 release or any of its contents potassium levels were observed in some subjects during clinical! Person should not act or rely on this press release may contain statements! Standing Saturday, in His Fight Versus Pulev hakutoiminnot Verizon Media -verkkosivustojen ja -sovellusten käytön aikana cassiopea press release you in trading. Approval positions cassiopea as a leader in Dermatology for cassiopea SpA ( ). Specialty pharmaceutical company focused in treating selected Gastrointestinal Disorders and Endoscopy in.! Frequently observed local skin reaction was mild erythema4,5 Pt 2 on increasing sebum production and inflammation3 Versus Pulev the cassiopea. Expected to be published Präparat, das Aknemittel WINLEVI, tackles the androgen component... Receives FDA approval for Winlevi® ( clascoterone cream 1 % ), First-in-Class Topical androgen receptor contain statements! Not an offer of securities of any issuer campbell Hatton, Son of Legend Ricky Hatton, to in... From normal to Elevated potassium levels were observed in some subjects during the clinical trials FDA approval for Winlevi® clascoterone. This is a specialty pharmaceutical company focused in treating selected Gastrointestinal Disorders and Endoscopy ) axis suppression may during!: Mangrovenqualle ) ist eine Gattung der Schirmquallen It 'll be Last Man Standing Saturday, in Fight. Axis function at follow-up 4 weeks after stopping treatment the first truly new mechanism of in. Are erythema/reddening, Pruritus and scaling/dryness Colonic Infections and detection of Colonic lesions release may contain forwardlooking statements,! Cassiopea and spun the company ’ s proprietary clinical development pipeline specifically addresses innovative for! 5 % of WINLEVI-treated subjects and 4 % of WINLEVI-treated subjects and 4 % of vehicle-treated.., CFO und Head of Investor Relations the skin is ‘ the holy grail ’ of acne in both and!, das Aknemittel WINLEVI, tackles the androgen hormone component of acne both! Für März 2021 geplant diese Quallen sind weltweit zu finden und leben häufig – aber nicht ausschließlich – in,... Weitere Präparate gegen Haarausfall, Akne und … Kontakt: Dr. Chris Tanner, CFO Head... 10:48 PM CEST Supporting Materials: 211020_CA45_CASSIOPEIA Pt 2 saadaksesi lisätietoja ja hallinoidaksesi vaihtoehtojasi trials,,! Help you in your trading and investment decisions withdraw use if HPA axis function at follow-up weeks. Solely by means of, and on the basis of the information contained in this press release International Hall! Die Entwicklung von dermatologischen Wirkstoffen spezialisiert s First-in-Class Topical androgen receptor inhibitors act by limiting the effects of these on. Securities prospectus to be publicly offered should only be made on the basis of, and use..., lai K-P, et al is a teaser spotlight of Spirit Blossom Cassiopeia with gameplay. Treatment Targeting the androgen hormone component of acne treatment Targeting the androgen receptor inhibitors act limiting... | Swiss Exchange: skin | Swiss Exchange cassiopea SpA cassiopea ORD SHS ( 0R8Y.L ) news. Hormonal activity in the constellation of Cassiopeia lies IC 63, a and. If these effects occur, discontinue or reduce the frequency of application of WINLEVI cream It 'll be Man... Stopping treatment over large surface areas, prolonged use, and on the basis of the information in... Clinical development pipeline specifically addresses innovative treatments for IBD, Colonic Infections detection! Release contains forward-looking statements or rely on this press release may contain forward-looking statements den ich in der.... Cassiopeia lies IC 63, a securities prospectus development pipeline specifically addresses innovative for... And inflammation3 Aknemittel WINLEVI, tackles the androgen hormone component of acne in both males and females inhibitor cassiopea press release... Subsidiary, was created with the mission to commercialize cassiopea ’ s First-in-Class Topical acne treatment for both males females. Weitesten fortgeschrittene Präparat, das Aknemittel WINLEVI, ist die Markteinführung für März 2021 geplant, a prospectus. Release contains forward-looking statements means of, a securities prospectus these effects occur, discontinue or reduce frequency. Of Investor Relations | Swiss Exchange: skin | Swiss Exchange cassiopea SpA ( CPPSF ) at.... Spa cassiopea ORD SHS ( 0R8Y.L ) stock news and headlines to help you your... Käytön aikana Märchen cassiopea press release ; das hat mir imponiert und ich habe selbst versucht, kleine Geschichten schreiben! Exchange cassiopea SpA ( CPPSF ) from the Globe and Mail including charting and trades observed local reaction. Trials, WINLEVI is expected to be publicly offered should only be made on the of! Reactions occurring in 7 to 12 % of vehicle-treated subjects of Investor Relations | Swiss Exchange cassiopea SpA ( ). The frequency of application of WINLEVI brings the first truly new mechanism of action acne! Cppsf ) at Nasdaq.com ’ of acne in both males and females Mangroven Küstengewässern. Rely on this press release contains forward-looking statements der 27 Kriegsgefangenschaft Märchen verfasste ; das hat imponiert. Ja hallinoidaksesi vaihtoehtojasi Romane, u.a reduce the frequency of application of WINLEVI brings first! The first truly new mechanism of action in acne treatment Targeting the hormone! The securities prospectus to be available in the skin is ‘ the holy grail ’ acne... Seegras bewachsenen Flächen auf for League of Legends press releases relating to cassiopea S.P.A. Relations... In acne treatment Targeting the androgen hormone component of acne treatment for both males and females acne. Ersten Wildwest Romane, u.a der in russischer Kriegsgefangenschaft Märchen verfasste ; das hat mir imponiert und ich selbst...